Pembrolizumab-induced autoimmune encephalitis in a patient with advanced non-small cell lung cancer: A case report.

Niki, Maiko; Nakaya, Aya; Kurata, Takayasu; Nakahama, Kahori; Yoshioka, Hiroshige; Kaneda, Toshihiko; Kibata, Kayoko; Ogata, Makoto; Nomura, Shosaku

Niki, Maiko; Nakaya, Aya; Kurata, Takayasu; Nakahama, Kahori; Yoshioka, Hiroshige; Kaneda, Toshihiko; Kibata, Kayoko; Ogata, Makoto; Nomura, Shosaku.

Afiliação

Niki M; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Nakaya A; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Kurata T; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Nakahama K; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Yoshioka H; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Kaneda T; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Kibata K; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Ogata M; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.
Nomura S; First Department of Internal Medicine, Kansai Medical University, Hirakata, Osaka 573-1010, Japan.

Mol Clin Oncol ; 10(2): 267-269, 2019 Feb.

Article em En | MEDLINE | ID: mdl-30680206

Palavras-chave

autoimmune encephalitis; immune checkpoint inhibitor; immune-related adverse event; non-small-cell lung cancer; pembrolizumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral / Tipos_de_cancer / Pulmao Base de dados: MEDLINE Idioma: En Revista: Mol Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Japão

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google